FDA Refuses to Review Moderna’s Flu Vaccine in Latest Setback

2026-02-10 - 23:35

(Bloomberg) — US regulators have refused to review Moderna Inc.’s novel mRNA flu vaccine, dealing a major blow to the company as it seeks more products beyond its Covid shot. Read More